Middle and inner ear malformations in two siblings exposed to valproic acid during pregnancy: a case report

Evelyne Van Houtte1, Jan Casselman2, Sandra Janssens3

  • 1ENT Department, University Hospital Ghent, Belgium.

Insights

Valproic acid (VPA) exposure during pregnancy can cause fetal valproate syndrome. This case report details middle and inner ear malformations in siblings with VPA exposure, the first such description.

Area of Science:

  • Teratology
  • Developmental Pediatrics
  • Otolaryngology

Background:

  • Valproic acid (VPA) is a recognized teratogen, associated with fetal valproate syndrome, characterized by distinct facial features, congenital anomalies, and developmental delays.
  • Conductive hearing loss is a potential complication, but specific inner and middle ear malformations linked to VPA exposure have not been extensively documented.

Observation:

  • This case report investigates two siblings diagnosed with fetal valproate syndrome and mild conductive hearing loss.
  • Radiologic imaging revealed malformations of the middle and inner ear structures in both affected children.

Findings:

  • The study provides the first documented evidence of middle and inner ear malformations in children with a history of in utero exposure to valproic acid.
  • Audiologic, vestibular, and motor assessments were conducted to further characterize the functional impact of these malformations.

Implications:

  • This finding highlights a previously unrecognized spectrum of physical anomalies associated with fetal valproate syndrome.
  • It suggests the need for routine audiological and potentially radiological screening in infants exposed to VPA during gestation.
  • Further research is warranted to elucidate the precise mechanisms underlying VPA-induced otic malformations and their long-term consequences.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
40.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K